FORTE BIOSCIENCES INC (FBRX) Fundamental Analysis & Valuation

NASDAQ:FBRX • US34962G2084

Current stock price

28.19 USD
+1.53 (+5.74%)
At close:
28.19 USD
0 (0%)
After Hours:

This FBRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. FBRX Profitability Analysis

1.1 Basic Checks

  • In the past year FBRX has reported negative net income.
  • FBRX had a negative operating cash flow in the past year.
  • FBRX had negative earnings in each of the past 5 years.
  • FBRX had a negative operating cash flow in each of the past 5 years.
FBRX Yearly Net Income VS EBIT VS OCF VS FCFFBRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • FBRX's Return On Assets of -83.81% is on the low side compared to the rest of the industry. FBRX is outperformed by 70.49% of its industry peers.
  • The Return On Equity of FBRX (-113.75%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -83.81%
ROE -113.75%
ROIC N/A
ROA(3y)-74.06%
ROA(5y)-61.07%
ROE(3y)-90.16%
ROE(5y)-71.71%
ROIC(3y)N/A
ROIC(5y)N/A
FBRX Yearly ROA, ROE, ROICFBRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FBRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FBRX Yearly Profit, Operating, Gross MarginsFBRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. FBRX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, FBRX has more shares outstanding
  • Compared to 5 years ago, FBRX has more shares outstanding
  • There is no outstanding debt for FBRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FBRX Yearly Shares OutstandingFBRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
FBRX Yearly Total Debt VS Total AssetsFBRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • FBRX has an Altman-Z score of 7.97. This indicates that FBRX is financially healthy and has little risk of bankruptcy at the moment.
  • FBRX has a better Altman-Z score (7.97) than 78.25% of its industry peers.
  • There is no outstanding debt for FBRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.97
ROIC/WACCN/A
WACCN/A
FBRX Yearly LT Debt VS Equity VS FCFFBRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • A Current Ratio of 3.88 indicates that FBRX has no problem at all paying its short term obligations.
  • FBRX has a Current ratio of 3.88. This is comparable to the rest of the industry: FBRX outperforms 46.80% of its industry peers.
  • FBRX has a Quick Ratio of 3.88. This indicates that FBRX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.88, FBRX is in line with its industry, outperforming 49.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.88
Quick Ratio 3.88
FBRX Yearly Current Assets VS Current LiabilitesFBRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. FBRX Growth Analysis

3.1 Past

  • FBRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.45%, which is quite impressive.
EPS 1Y (TTM)73.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -6.13% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y10.86%
EPS Next 2Y2.94%
EPS Next 3Y-0.52%
EPS Next 5Y-6.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FBRX Yearly Revenue VS EstimatesFBRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2030 2031 2032 2033 200M 400M 600M
FBRX Yearly EPS VS EstimatesFBRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K -2K

More info and screens

Find the best growth stocksShow best growing peers

0

4. FBRX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FBRX. In the last year negative earnings were reported.
  • Also next year FBRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FBRX Price Earnings VS Forward Price EarningsFBRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FBRX Per share dataFBRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.94%
EPS Next 3Y-0.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FBRX Dividend Analysis

5.1 Amount

  • FBRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FBRX Fundamentals: All Metrics, Ratios and Statistics

FORTE BIOSCIENCES INC

NASDAQ:FBRX (5/1/2026, 8:25:02 PM)

After market: 28.19 0 (0%)

28.19

+1.53 (+5.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners81.47%
Inst Owner Change0.2%
Ins Owners0.98%
Ins Owner Change2.34%
Market Cap526.03M
Revenue(TTM)N/A
Net Income(TTM)-69.38M
Analysts83.33
Price Target54.32 (92.69%)
Short Float %4.96%
Short Ratio2.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.62%
Min EPS beat(2)-12.31%
Max EPS beat(2)9.08%
EPS beat(4)2
Avg EPS beat(4)-7.4%
Min EPS beat(4)-41.38%
Max EPS beat(4)15.02%
EPS beat(8)5
Avg EPS beat(8)-2.43%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.83%
PT rev (3m)-2.83%
EPS NQ rev (1m)-19.5%
EPS NQ rev (3m)-21.94%
EPS NY rev (1m)-9.25%
EPS NY rev (3m)-5.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.62
P/tB 8.62
EV/EBITDA N/A
EPS(TTM)-4.71
EYN/A
EPS(NY)-4.2
Fwd EYN/A
FCF(TTM)-2.73
FCFYN/A
OCF(TTM)-2.73
OCFYN/A
SpS0
BVpS3.27
TBVpS3.27
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -83.81%
ROE -113.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-74.06%
ROA(5y)-61.07%
ROE(3y)-90.16%
ROE(5y)-71.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 181.25%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.88
Quick Ratio 3.88
Altman-Z 7.97
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)417.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.27%
EPS Next Y10.86%
EPS Next 2Y2.94%
EPS Next 3Y-0.52%
EPS Next 5Y-6.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.5%
OCF growth 3YN/A
OCF growth 5YN/A

FORTE BIOSCIENCES INC / FBRX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for FORTE BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 2 / 10 to FBRX.


What is the valuation status for FBRX stock?

ChartMill assigns a valuation rating of 0 / 10 to FORTE BIOSCIENCES INC (FBRX). This can be considered as Overvalued.


How profitable is FORTE BIOSCIENCES INC (FBRX) stock?

FORTE BIOSCIENCES INC (FBRX) has a profitability rating of 0 / 10.


What is the earnings growth outlook for FORTE BIOSCIENCES INC?

The Earnings per Share (EPS) of FORTE BIOSCIENCES INC (FBRX) is expected to grow by 10.86% in the next year.